Clinical Trial Update: Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in previously untreated symptomatic multiple myeloma or AL amyloidosis. The trial has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis
• Multiple Myeloma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Decadron (Dexamethasone)
• NINLARO (ixazomib)

Snippet

Sponsor: Mayo Clinic | Conditions: Amyloidosis, Plasma Cell Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-09-21